The Swiss stock market climbed on Tuesday, with the tailwind of the heavyweights of the pharmaceutical and food sector, a new record high. The benchmark index SMI was up nearly 0.7 per cent on 9636 counter, the highest value since its introduction over 30 years ago.
After the Win last week, investors are increasingly regarded as secure values such as Novartis, Roche or nestlé. Clock stating the current reporting season for the first quarter, and many analysts, trials in the Wake of the published results.
development of the SMI since 1988. Chart: Finanz und Wirtschaft (fuw.ch)
the Biggest winners, the title of Lonza with a Plus of four per cent. The suppliers to the Pharmaceutical industry benefited from positive analyst comments. The pharmaceutical companies Roche and Novartis were up by 1.6 and 1.2 percent. Novartis plans to submit on Wednesday its quarterly balance sheet. Analysts expect a decline in adjusted net profit.
Nestle shares 1.2 percent. Also the food group were positive comments after the presentation of the quarterly benefit figures last week.
among the losers in Finance, in contrast, values of: The title of the Credit Suisse gave on the day prior to the quarterly balance of 1.5 per cent. The shares of rival UBS lost 0.4 percent. You want to present its balance sheet on Thursday and had already warned of lower revenues in the major business share. (Reuters)
Created: 23.04.2019, 18:04 PM